Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
TREX1 acts in concert with the SET complex in granzyme A-mediated apoptosis, and mutations in TREX1 cause Aicardi-Goutières syndrome and familial chilblain lupus. Here, we report monoallelic frameshift or missense mutations and one 3' UTR variant of TREX1 present in 9/417 individuals with systemic lupus erythematosus but absent in 1,712 controls (P = 4.1 x 10(-7)). We demonstrate that two mutant TREX1 alleles alter subcellular targeting. Our findings implicate TREX1 in the pathogenesis of SLE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREX1 mutations have been identified in SLE115 and familial chilblain lupus116, implicating TREX1 as a safeguard against autoimmune inflammation.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [115]
Citations
Cites
Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune Response
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.003 · Cited by 1,008
Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1845 · Cited by 903
Features of systemic lupus erythematosus in Dnase1-deficient mice
Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H. G., & Möröy, T. (2000) · Nature Genetics · doi:10.1038/76032 · Cited by 789
Mutation of DNASE1 in people with systemic lupus erythematosus
Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., & Kuroda, Y. (2001) · Nature Genetics · doi:10.1038/91070 · Cited by 596
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., Yoshikawa, H., & Nagata, S. (2006) · Nature · doi:10.1038/nature05245 · Cited by 470
Rice, G., Newman, W. G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O’Hara, A., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/513443 · Cited by 410
Self-citationMorita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., Daly, G., Lindahl, T., & Barnes, D. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6719-6727.2004 · Cited by 380
Mendell, J. T., & Dietz, H. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00583-9 · Cited by 289
Role and fate of PML nuclear bodies in response to interferon and viral infections
Regad, T., & Chelbi-Alix, M. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204854 · Cited by 281
Mazur, D. J., & Perrino, F. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19655 · Cited by 276
Self-citation
Cited by
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
“Similarly, deficiency in DNase I, a major DNase present in serum, results in the generation of SLE-like autoimmune disease in mice; a mutation in DNase I has been identified in human SLE patients (Lee-Kirsch et al., 2007).”
BackgroundThe role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
“Mutations in the gene encoding the repair exonuclease TREX1 are found in Aicardi-Goutieres syndrome, which is characterized by a fatal encephalopathy associated with greater production of type I interfero”
BackgroundThe cGAS–STING pathway as a therapeutic target in inflammatory diseases
Decout, A., Katz, J. D., Venkatraman, S., & Ablasser, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00524-z · Cited by 2,309
Molecular mechanisms and cellular functions of cGAS–STING signalling
Hopfner, K.-P., & Hornung, V. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0244-x · Cited by 2,052
The roles of TLRs, RLRs and NLRs in pathogen recognition
Kawai, T., & Akira, S. (2009) · International Immunology · doi:10.1093/intimm/dxp017 · Cited by 1,670
Intracellular Toll-like Receptors
Blasius, A. L., & Beutler, B. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.012 · Cited by 1,325
The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley, J. B., Alarcón-Riquelme, M. E., Criswell, L. A., Jacob, C. O., Kimberly, R. P., Moser, K. L., Tsao, B. P., Vyse, T. J., & Langefeld, C. D. (2008) · Nature Genetics · doi:10.1038/ng.81 · Cited by 1,309
Self-citationTrex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280
“Trex1 contains a predicted transmembrane helix at its C terminus , suggesting that it may be an integral membrane protein of the ER (Lee-Kirsch et al., 2007b).”
cGAS in action: Expanding roles in immunity and inflammation
Ablasser, A., & Chen, Z. J. (2019) · Science · doi:10.1126/science.aat8657 · Cited by 1,077
Aicardi–Goutières syndrome and the type I interferonopathies
Crow, Y. J., & Manel, N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3850 · Cited by 925
Mitochondrial DNA in inflammation and immunity
Riley, J. S., & Tait, S. W. (2020) · EMBO reports · doi:10.15252/embr.201949799 · Cited by 865
Activation of STING requires palmitoylation at the Golgi
Mukai, K., Konno, H., Akiba, T., Uemura, T., Waguri, S., Kobayashi, T., Barber, G. N., Arai, H., & Taguchi, T. (2016) · Nature Communications · doi:10.1038/ncomms11932 · Cited by 710
“Mice lacking DNase II or DNase III (Trex1) die during embryonic development or within 10 weeks of birth, respectively, with inflammation-related phenotypes.”
InfluentialThe Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment
Bakhoum, S. F., & Cantley, L. C. (2018) · Cell · doi:10.1016/j.cell.2018.08.027 · Cited by 717
Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
Crow, Y. J., Chase, D. S., Lowenstein Schmidt, J., Szynkiewicz, M., Forte, G. M. A., Gornall, H. L., Oojageer, A., Anderson, B., Pizzino, A., Helman, G., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36887 · Cited by 595
“PatientswithbothAGSandSLEwerefirst describedover 14years ago [Aicardi and Goutieres, 2000; Dale et al., 2000], and heterozygous mutations in TREX1 have been identified in non-syndromic lupus [Lee-Kirsch et al., 2007].”
BackgroundTrex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease
Yang, Y.-G., Lindahl, T., & Barnes, D. E. (2007) · Cell · doi:10.1016/j.cell.2007.10.017 · Cited by 579
“More recently, certain heterozygous TREX1 mutations have been implicated in SLE, as well as dominant AGS and other distinct monogenic diseases (Lee-Kirsch et al., 2007a, 2007b; Rice et al., 2007a; Richards et al., 2007).”
BackgroundRecognition of Endogenous Nucleic Acids by the Innate Immune System
Roers, A., Hiller, B., & Hornung, V. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.002 · Cited by 541
Yan, N., Regalado-Magdos, A. D., Stiggelbout, B., Lee-Kirsch, M. A., & Lieberman, J. (2010) · Nature Immunology · doi:10.1038/ni.1941 · Cited by 529
“TREX1 mutations are associated with inflammatory and autoimmune diseases, including Aicardi-Goutieres syndrome, chilblain lupus, and systemic lupus erythematosus, some of which have more type I interfero”
Self-citationGall, A., Treuting, P., Elkon, K. B., Loo, Y.-M., Gale, M., Barber, G. N., & Stetson, D. B. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.018 · Cited by 510
“…of Trex1 mutations in AGS, dozens of distinct mutations within the human Trex1 open reading frame have been discovered in the context of several disease phenotypes, including chilblain lupus and SLE (de Vries et al., 2010; Lee-Kirsch et al., 2007; Namjou et al., 2011; Rice et al., 2007a).”
The type I interferonopathies: 10 years on
Crow, Y. J., & Stetson, D. B. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00633-9 · Cited by 489
Restricting retrotransposons: a review
Goodier, J. L. (2016) · Mobile DNA · doi:10.1186/s13100-016-0070-z · Cited by 436
“TREX1 mutations are also implicated in other autoimmune conditions, including systemic lupus erythematous, chilblain lupus, and retinal vasculopathy with cerebral leukodystrophy [494, 495].”
BackgroundGehrke, N., Mertens, C., Zillinger, T., Wenzel, J., Bald, T., Zahn, S., Tüting, T., Hartmann, G., & Barchet, W. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.004 · Cited by 473
“In particular, TREX1 has been shown to prevent buildup of immunostimulatory DNA in the cytosol (Stetson et al., 2008), and TREX1 defects have been described as the first monogenetic cause for severe LE, accounting for 0.5% of lupus cases (Lee-Kirsch et al., 2007).”
BackgroundInfluentialThe role of retrotransposable elements in ageing and age-associated diseases
Gorbunova, V., Seluanov, A., Mita, P., McKerrow, W., Fenyö, D., Boeke, J. D., Linker, S. B., Gage, F. H., Kreiling, J. A., Petrashen, A. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03542-y · Cited by 446
Innate immune signaling and regulation in cancer immunotherapy
Corrales, L., Matson, V., Flood, B., Spranger, S., & Gajewski, T. F. (2017) · Cell Research · doi:10.1038/cr.2016.149 · Cited by 408
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity
Ferguson, B. J., Mansur, D. S., Peters, N. E., Ren, H., & Smith, G. L. (2012) · eLife · doi:10.7554/elife.00047 · Cited by 404
“Trex1 deficiency or mutation, on the other hand, is associated with systemic lupus erythematosus (SLE), chilblain lupus and the human disease Aicardi-Goutières syndrome (AGS) (Lee-Kirsch et al., 2007a, 2007b; Stetson et al., 2008) and in this case inflammation is initiated from non-haematopoietic cells via a STING-dep…”
BackgroundType I interferonopathies: a novel set of inborn errors of immunity
Crow, Y. J. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06220.x · Cited by 404
TLR9 as a key receptor for the recognition of DNA☆
KUMAGAI, Y., TAKEUCHI, O., & AKIRA, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.12.004 · Cited by 387
Gray, E. E., Treuting, P. M., Woodward, J. J., & Stetson, D. B. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500969 · Cited by 384
Genetic susceptibility to systemic lupus erythematosus in the genomic era
Deng, Y., & Tsao, B. P. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.176 · Cited by 379
“A study of populations from the UK, Germany and Finland reported monoallelic frameshift or missense mutations and a single 3' UTR variant of TREX1 present in patients with SLE, all of which were absent in controls”
BackgroundPathogenesis of human systemic lupus erythematosus: recent advances
Crispín, J. C., Liossis, S.-N. C., Kis-Toth, K., Lieberman, L. A., Kyttaris, V. C., Juang, Y.-T., & Tsokos, G. C. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.12.005 · Cited by 359
Sankowski, R., Mader, S., & Valdés-Ferrer, S. I. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00028 · Cited by 351
“These findings indicate that DNA–NMDA receptor antibodies are directly involved in neurodegenerative processes in SLE.”
BackgroundInfluentialRecent Advances in the Genetics of Autoimmune Disease
Gregersen, P. K., & Olsson, L. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132653 · Cited by 339
STING-dependent cytosolic DNA sensing pathways
Barber, G. N. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.010 · Cited by 336
Bradley, K. C., Finsterbusch, K., Schnepf, D., Crotta, S., Llorian, M., Davidson, S., Fuchs, S. Y., Staeheli, P., & Wack, A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.105 · Cited by 313
Role of the cGAS–STING pathway in systemic and organ-specific diseases
Skopelja-Gardner, S., An, J., & Elkon, K. B. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00589-6 · Cited by 307
Type I interferon in rheumatic diseases
Muskardin, T. L. W., & Niewold, T. B. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.31 · Cited by 308
Hansen, A. L., Buchan, G. J., Rühl, M., Mukai, K., Salvatore, S. R., Ogawa, E., Andersen, S. D., Iversen, M. B., Thielke, A. L., Gunderstofte, C., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806239115 · Cited by 299
Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies
Harley, I. T. W., Kaufman, K. M., Langefeld, C. D., Harley, J. B., & Kelly, J. A. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2571 · Cited by 297
Type I Interferons in Autoimmune Disease
Crow, M. K., Olferiev, M., & Kirou, K. A. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043952 · Cited by 291
Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity
Crow, Y. J., & Rehwinkel, J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp293 · Cited by 289
Hartmann, G. (2017) · Advances in Immunology · doi:10.1016/bs.ai.2016.11.001 · Cited by 285
Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases
Duvvuri, B., & Lood, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00502 · Cited by 282
“TREX1 variant mutations are also reported in SLE (89, 90).”
BackgroundEvaluation of the TREX1 gene in a large multi-ancestral lupus cohort
Namjou, B., Kothari, P. H., Kelly, J. A., Glenn, S. B., Ojwang, J. O., Adler, A., Alarcón-Riquelme, M. E., Gallant, C. J., Boackle, S. A., Criswell, L. A., et al. (2011) · Genes & Immunity · doi:10.1038/gene.2010.73 · Cited by 281
Self-citationBarber, G. N. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.12.015 · Cited by 278
STING inhibitors target the cyclic dinucleotide binding pocket
Hong, Z., Mei, J., Li, C., Bai, G., Maimaiti, M., Hu, H., Yu, W., Sun, L., Zhang, L., Cheng, D., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105465118 · Cited by 273
“Flag-STING(138-379) Flag-STING(1-341) Flag-STING(del138-340) Flag-STING Flag-STING(138-379) Flag-STING(1-341)”
BackgroundSelf-citationCap binding and immune evasion revealed by Lassa nucleoprotein structure
Qi, X., Lan, S., Wang, W., Schelde, L. M., Dong, H., Wallat, G. D., Ly, H., Liang, Y., & Dong, C. (2010) · Nature · doi:10.1038/nature09605 · Cited by 277
Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion
Nader, G. P. D. F., Agüera-Gonzalez, S., Routet, F., Gratia, M., Maurin, M., Cancila, V., Cadart, C., Palamidessi, A., Ramos, R. N., San Roman, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.035 · Cited by 265
Caforio, A. L. P., Adler, Y., Agostini, C., Allanore, Y., Anastasakis, A., Arad, M., Böhm, M., Charron, P., Elliott, P. M., Eriksson, U., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx321 · Cited by 263
The enemy within: endogenous retroelements and autoimmune disease
Volkman, H. E., & Stetson, D. B. (2014) · Nature Immunology · doi:10.1038/ni.2872 · Cited by 333
Briggs, T. A., Rice, G. I., Daly, S., Urquhart, J., Gornall, H., Bader-Meunier, B., Baskar, K., Baskar, S., Baudouin, V., Beresford, M. W., et al. (2011) · Nature Genetics · doi:10.1038/ng.748 · Cited by 261
“In relation to SLE, together with deficiency of early components of the classical complement pathway 17 and mutations in TREX1 18 , TRAP deficiency now represents a third monogenic disorder associated with the development of lupus also showing an up-regulation of type I interferon activity 19 , 20 , 21 .”
Ribonuclease H2 mutations induce a cGAS/STING‐dependent innate immune response
Mackenzie, K. J., Carroll, P., Lettice, L., Tarnauskaitė, Ž., Reddy, K., Dix, F., Revuelta, A., Abbondati, E., Rigby, R. E., Rabe, B., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593339 · Cited by 248
“The variation in severity between different AGS gene mouse models remains unexplained, although it may be meaningful that mutations in human RNASEH2B are associated with the least severe disease course, with AGS onset generally in infancy, in contrast to the prenatal/neonatal onset more commonly seen in TREX1 patients…”
InfluentialCytoplasmic DNA innate immune pathways
Barber, G. N. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01051.x · Cited by 245
Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity
Hiller, B., Achleitner, M., Glage, S., Naumann, R., Behrendt, R., & Roers, A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120876 · Cited by 245
“Mutations of Trex1 are associated with human lupus (Lee-Kirsch et al., 2007), and Trex1 deficiency results in type I IFN–dependent multi-organ inflammation in mice (Morita et al., 2004; Stetson et al., 2008; Gall et al., 2012).”
BackgroundDesigning DNA nanodevices for compatibility with the immune system of higher organisms
Surana, S., Shenoy, A. R., & Krishnan, Y. (2015) · Nature Nanotechnology · doi:10.1038/nnano.2015.180 · Cited by 243
An, J., Woodward, J. J., Sasaki, T., Minie, M., & Elkon, K. B. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402793 · Cited by 239
Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy
Lan, Y. Y., Londoño, D., Bouley, R., Rooney, M. S., & Hacohen, N. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.074 · Cited by 236
“…mutations in Dnase1 (Napirei et al., 2000; Yasutomo et al., 2001), Dnase2 (Kawane et al., 2006, 2010), and Dnase3/Trex1 (Crow et al., 2006; Lee-Kirsch et al., 2007; Morita et al., 2004) enable self DNA originating from apoptotic cells (Yoshida et al., 2005) or retroelements (Stetson et…”
Type I interferon-mediated autoinflammation due to DNase II deficiency
Rodero, M. P., Tesser, A., Bartok, E., Rice, G. I., Della Mina, E., Depp, M., Beitz, B., Bondet, V., Cagnard, N., Duffy, D., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01932-3 · Cited by 233
R Loops and Links to Human Disease
Richard, P., & Manley, J. L. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.031 · Cited by 226
Immunogenetics of systemic lupus erythematosus: A comprehensive review
Ghodke-Puranik, Y., & Niewold, T. B. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.004 · Cited by 225
“7% SLE patients but were nearly absent in healthy controls indicating TREX1 mutations are the most frequent form of monogenic lupus [86, 87].”
BackgroundSystemic Lupus Erythematosus Pathogenesis: Interferon and Beyond
Caielli, S., Wan, Z., & Pascual, V. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-042422 · Cited by 224
Role of type I interferons in the activation of autoreactive B cells
Kiefer, K., Oropallo, M. A., Cancro, M. P., & Marshak‐Rothstein, A. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2012.10 · Cited by 223
Intracellular Nucleic Acid Detection in Autoimmunity
Crowl, J. T., Gray, E. E., Pestal, K., Volkman, H. E., & Stetson, D. B. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052331 · Cited by 223
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity
Günther, C., Kind, B., Reijns, M. A. M., Berndt, N., Martinez-Bueno, M., Wolf, C., Tüngler, V., Chara, O., Lee, Y. A., Hübner, N., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78001 · Cited by 222
“Mutations in other enzymes involved in the intracellular nucleic acid metabolism — the DNA exonuclease 3 ′ repair exonuclease 1 ( TREX1 ), the triphospho-hydrolase SAM domain and HD domain-containing protein 1 ( SAMHD1 ), and the RNA-editing enzyme adenosine deaminase 1 acting on RNA ( ADAR ) — have also been implicat…”
BackgroundInfluentialSelf-citationThe interferon-α signature of systemic lupus erythematosus
Obermoser, G., & Pascual, V. (2010) · Lupus · doi:10.1177/0961203310371161 · Cited by 220
Recognition of nucleic acids by pattern‐recognition receptors and its relevance in autoimmunity
Kawasaki, T., Kawai, T., & Akira, S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01048.x · Cited by 217
“However, a sensor for accumulated DNA by dysregulation of the relevant DNases has not been demonstrated.”
BackgroundExpanding the phenotypic spectrum of lupus erythematosus in Aicardi‐Goutières syndrome
Ramantani, G., Kohlhase, J., Hertzberg, C., Innes, A. M., Engel, K., Hunger, S., Borozdin, W., Mah, J. K., Ungerath, K., Walkenhorst, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27367 · Cited by 213
Self-citationSTING-Mediated DNA Sensing Promotes Antitumor and Autoimmune Responses to Dying Cells
Klarquist, J., Hennies, C. M., Lehn, M. A., Reboulet, R. A., Feau, S., & Janssen, E. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401869 · Cited by 211
Lee-Kirsch, M. A. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104506 · Cited by 210
Self-citationER-directed TREX1 limits cGAS activation at micronuclei
Mohr, L., Toufektchan, E., von Morgen, P., Chu, K., Kapoor, A., & Maciejowski, J. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.12.037 · Cited by 204
“Finally, frameshift mutations that eliminate TREX1’s C-terminal extension are associated with systemic lupus erythematosus (SLE) and retinal vasculopathy with cerebral leukodystrophy (RVCL) (Lee-Kirsch et al., 2007; Richards et al., 2007).”
BackgroundResultInfluentialHuman Disease Phenotypes Associated With Mutations in TREX1
Rice, G. I., Rodero, M. P., & Crow, Y. J. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0147-3 · Cited by 205
“However, despite the absence of any conventional immune phenotype in RVCL patients, 2 frameshift mutations in the C-terminus of the gene have been reported to be associated with SLE [48], and a C terminus frameshift mutation has 240 J Clin Immunol (2015) 35:235–243”
BackgroundBelot, A., Kasher, P. R., Trotter, E. W., Foray, A., Debaud, A., Rice, G. I., Szynkiewicz, M., Zabot, M., Rouvet, I., Bhaskar, S. S., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38008 · Cited by 203
“Monogenic cases of juvenile-onset SLE or SLElike phenotypes due to mutations in complement system genes (C1QA, C1QB, C1QC, C4A, C4B, C2) (6), ACP5 (7,8), TREX1 (9), and DNASE1L3 (10) have been reported.”
Aicardi-Goutières Syndrome Is Caused by IFIH1 Mutations
Oda, H., Nakagawa, K., Abe, J., Awaya, T., Funabiki, M., Hijikata, A., Nishikomori, R., Funatsuka, M., Ohshima, Y., Sugawara, Y., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.06.007 · Cited by 203
Cardiac Manifestations of Systemic Lupus Erythematosus
Miner, J. J., & Kim, A. H. J. (2014) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2013.10.003 · Cited by 203
Toll-like receptor driven B cell activation in the induction of systemic autoimmunity
Green, N. M., & Marshak-Rothstein, A. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.016 · Cited by 199
“A broad role for endogenous retroviruses in human SLE has not been clearly demonstrated, but there is a genetic association between two rare TREX1 mutations and SLE [92].”
BackgroundExpression of Cyclic GMP‐AMP Synthase in Patients With Systemic Lupus Erythematosus
An, J., Durcan, L., Karr, R. M., Briggs, T. A., Rice, G. I., Teal, T. H., Woodward, J. J., & Elkon, K. B. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40002 · Cited by 198
“It is relevant to point out that 1– 2% of SLE patients have mutations in TREX1 which are thought to contribute to the lupuslike syndrome (35, 36).”
BackgroundCorrales, L., & Gajewski, T. F. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1362 · Cited by 197
“Pathological accumulation of cytosolic DNA leads to autoimmune diseases such as Aicardi-Goutières syndrome (15) or systemic lupus erythematosus (SLE) (16).”
BackgroundObermoser, G., Sontheimer, R., & Zelger, B. (2010) · Lupus · doi:10.1177/0961203310370048 · Cited by 190
Gallo, P. M., & Gallucci, S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00138 · Cited by 190
“Loss-offunction mutations in Trex1 are present in patients with Aicardi– Goutières syndrome as well as other autoimmune diseases such as familial chilblain lupus (Lee-Kirsch et al., 2007a; Gunther et al., 2009) and SLE (Lee-Kirsch et al., 2007b; Hur et al., 2008).”
BackgroundGenome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi–Goutières syndrome
Lim, Y. W., Sanz, L. A., Xu, X., Hartono, S. R., & Chédin, F. (2015) · eLife · doi:10.7554/elife.08007 · Cited by 188
“While additional samples encompassing other AGS mutations subtypes will need to be studied to confirm this trend, this observation nonetheless reinforces the similarities between AGS and SLE, although the DNA hypomethylation reported here is stronger than that previously reported in SLE.”
BackgroundInfluentialMavragani, C. P., Sagalovskiy, I., Guo, Q., Nezos, A., Kapsogeorgou, E. K., Lu, P., Liang Zhou, J., Kirou, K. A., Seshan, S. V., Moutsopoulos, H. M., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39795 · Cited by 187
The AIM2-like Receptors Are Dispensable for the Interferon Response to Intracellular DNA
Gray, E. E., Winship, D., Snyder, J. M., Child, S. J., Geballe, A. P., & Stetson, D. B. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.015 · Cited by 187
Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles
Vanpouille-Box, C., Hoffmann, J. A., & Galluzzi, L. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0043-2 · Cited by 183
Grieves, J. L., Fye, J. M., Harvey, S., Grayson, J. M., Hollis, T., & Perrino, F. W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423804112 · Cited by 181
Self-citationTeruel, M., & Alarcón-Riquelme, M. E. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.08.001 · Cited by 177
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
Stam, A. H., Kothari, P. H., Shaikh, A., Gschwendter, A., Jen, J. C., Hodgkinson, S., Hardy, T. A., Hayes, M., Kempster, P. A., Kotschet, K. E., et al. (2016) · Brain · doi:10.1093/brain/aww217 · Cited by 174
“Mutations abolishing TREX1 exonuclease activity have been associated with three autoimmune diseases in humans: AGS, autosomal dominant familial chilblain lupus (FCL), and systemic lupus erythematosus (SLE).”
BackgroundInfluentialSelf-citationThe cytosolic DNA sensor cGAS recognizes neutrophil extracellular traps
Apel, F., Andreeva, L., Knackstedt, L. S., Streeck, R., Frese, C. K., Goosmann, C., Hopfner, K.-P., & Zychlinsky, A. (2021) · Science Signaling · doi:10.1126/scisignal.aax7942 · Cited by 173
STING signaling and host defense against microbial infection
Ahn, J., & Barber, G. N. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0333-0 · Cited by 171
Suppression of systemic autoimmunity by the innate immune adaptor STING
Sharma, S., Campbell, A. M., Chan, J., Schattgen, S. A., Orlowski, G. M., Nayar, R., Huyler, A. H., Nündel, K., Mohan, C., Berg, L. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420217112 · Cited by 170
Hall, J., Brault, A., Vincent, F., Weng, S., Wang, H., Dumlao, D., Aulabaugh, A., Aivazian, D., Castro, D., Chen, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0184843 · Cited by 167
Nuclear Membrane Rupture and Its Consequences
Maciejowski, J., & Hatch, E. M. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-020520-120627 · Cited by 166
“Interestingly, these mutations compromise TREX1 association with the ER but do not affect its catalytic activity (Lee-Kirsch et al. 2007).”
BackgroundTumefactive demyelination: an approach to diagnosis and management
Hardy, T. A., & Chataway, J. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304498 · Cited by 165
Monogenic Lupus: A Developing Paradigm of Disease
Alperin, J. M., Ortiz-Fernández, L., & Sawalha, A. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02496 · Cited by 163
Functionally defective germline variants of sialic acid acetylesterase in autoimmunity
Surolia, I., Pirnie, S. P., Chellappa, V., Taylor, K. N., Cariappa, A., Moya, J., Liu, H., Bell, D. W., Driscoll, D. R., Diederichs, S., et al. (2010) · Nature · doi:10.1038/nature09115 · Cited by 161
RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA
Wolf, C., Rapp, A., Berndt, N., Staroske, W., Schuster, M., Dobrick-Mattheuer, M., Kretschmer, S., König, N., Kurth, T., Wieczorek, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11752 · Cited by 161
Self-citationClinical implications of shared genetics and pathogenesis in autoimmune diseases
Zhernakova, A., Withoff, S., & Wijmenga, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.161 · Cited by 158
Deoxyribonucleases and Their Applications in Biomedicine
Lauková, L., Konečná, B., Janovičová, Ľ., Vlková, B., & Celec, P. (2020) · Biomolecules · doi:10.3390/biom10071036 · Cited by 182
Behrendt, R., Schumann, T., Gerbaulet, A., Nguyen, L. A., Schubert, N., Alexopoulou, D., Berka, U., Lienenklaus, S., Peschke, K., Sutter, K., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.037 · Cited by 179
“The finding that a rare monogenic form of lupus can also be caused by mutations in TREX1 (Lee-Kirsch et al., 2007a; Rice et al., 2007a) or SAMHD1 (Ravenscroft et al., 2011), as well as the identification of SLE patients carrying mutations in TREX1 (Lee-Kirsch et al., 2007b) and a report of the…”
Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA
Corrales, L. P., Woo, S., Williams, J. B., McWhirter, S. M., Dubensky, T. W., & Gajewski, T. F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502538 · Cited by 160
The genetics of SLE: an update in the light of genome-wide association studies
Rhodes, B., & Vyse, T. J. (2008) · Rheumatology · doi:10.1093/rheumatology/ken247 · Cited by 163
Self-citationA Genomic Approach to Human Autoimmune Diseases
Pascual, V., Chaussabel, D., & Banchereau, J. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101221 · Cited by 161
Metadata
- Authors
- Lee-Kirsch, M. A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.-A., de Silva, U., Bailey, S. L., Witte, T., Vyse, T. J., Kere, J., Pfeiffer, C., Harvey, S., Wong, A., Koskenmies, S., Hummel, O., Rohde, K., Schmidt, R. E., Dominiczak, A. F., Gahr, M., Hollis, T., Perrino, F. W., Lieberman, J., & Hübner, N.
- Affiliations
- Max Delbrück Center (DE)
- Harvard University (US)
- Technische Universität Dresden (DE)
- Wake Forest University Health Sciences (US)
- Medizinische Hochschule Hannover (DE)
- Hammersmith Hospital (GB)
- Karolinska Institutet (SE)
- Klinik und Poliklinik für Dermatologie (DE)
- University of Helsinki (FI)
- University of Glasgow (GB)
- Corresponding author
- Lee, Young-Ae
- Hübner, Norbert
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-07-29
- Volume
- 39
- Issue
- 9
- Pages
- 1065-1067
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2043959346
- Semantic Scholar
- 443992a86650d6f5f9c909d94b91ccce78822316
- Cited by
- 730
- References
- 15
- Citations by year
- 2026: 21 · 2025: 31 · 2024: 57 · 2023: 32 · 2022: 30 · 2021: 36 · 2020: 23 · 2019: 44 · 2018: 34 · 2017: 39 · 2016: 48 · 2015: 43 · 2014: 38 · 2013: 57 · 2012: 48
- FWCI
- 25.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM069962, GM 069962)
- National Institute of Allergy and Infectious Diseases (AI45587)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREX1, systemic lupus erythematosus, 3'-5' exonuclease, Aicardi-Goutières syndrome, monoallelic variants, frameshift mutation, missense mutations, 3'UTR variant, subcellular targeting, genetic susceptibility
- MeSH terms
- Exodeoxyribonucleases, Gene Frequency, Genotype, HeLa Cells, Humans, Lupus Erythematosus, Cutaneous, Mutation, Phosphoproteins, Endosomes, Recombinant Proteins, Frameshift Mutation, Protein Structure, Tertiary, Genetic Predisposition to Disease, Mutation, Missense, 3' Untranslated Regions, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.